SCIENTIFIC PROGRAM

19:00 – 19:15 Conference Chairman’s Opening Remarks Dr. Mubarak Almansour

Welcome Address & Speakers Introduction Moderators

19:15 –19:35 Curing Advanced Hodgkin Lymphoma: PET Guidance and Novel Agents

19:35 – 19:45 Discussion : Question & Answer

19:45 – 20:05 Relapsed/Refractory Hodgkin Lymphoma

20:05 - 20:15 Discussion: Question & Answer

20:15–21:00 Satellite Symposium -Takeda Company

“Role of Brentuximab Vedotin in Advanced Stage Newly Diagnosed HL”

SESSION 2: DIFFUSE LARGE B-CELL LYMPHOMA Moderators: Dr. Ahmed Absi & Dr. Ayman AlHejazi21:00 – 21:30 Where is the Treatment of Di�use Large B-Cell Heading?

21:30 – 21:40 Discussion : Question & Answer

21:40 – 22:00 What is the Management Strategy for the Relapsed/Refractory DLBCL Lymphoma 2021?

22:00 – 22:10 Discussion : Question & Answer

22:10 – 22:20 Wrap Up & Conclusion Moderators

22:10 Closing Remarks Dr. Mubarak Almansour

Dr. Craig Moskowitz

Dr. Joseph Connors

Dr. Joseph Connors

Dr. Grzegorz Nowakowski

Dr. Laurie Sehn

14:00 - 14:10 Conference Chairman’s Opening Remarks Dr. Mubarak Almansour

14:10 – 14:20 Welcome Address & Speakers Introduction Moderators SESSION 3: FOLLICULAR LYMPHOMA Moderators: Dr. Ahmad Al Saeed & Dr. John Apostolidis14:20 – 14:40 Management of Follicular Lymphoma in 2021

14:40 – 14:50 Discussion : Question & Answer

14:50 – 15:10 What is the Best Management Strategy for Relapsed/Refractory Follicular Lymphoma 2021?

15:10 – 15:20 Discussion: Question & Answer

15:20 – 16:05 Satellite Symposium - Roche Company

“KSA Experience in the Management of R/R DLBCL”

16:05 – 16:20 Asr Prayer Break

SESSION 4: MANTLE CELL LYMPHOMA Moderators: Dr. Abdulaziz Hamadah & Dr. Moussab Damlaj16:20 – 16:40 Upfront Management of Mantle Cell Lymphoma in 2021

16:40 – 16:50 Discussion : Question & Answer

16:50 – 17:20 Relapsed/Refractory Mantle Cell Lymphoma

17:20 – 17:30 Discussion : Question & Answer

SESSION 5: CAR-T LYMPHOMA Moderator : Dr. Mahmoud Deeb AlJurf17:30 – 17:50 The Emerging Role of CAR-T in Non Hodgkin Lymphoma

17:50 – 18:00 Discussion : Question & Answer

18:00 – 18:10 Wrap Up & Conclusion Moderators

18:10 Closing Remarks Dr. Mubarak Almansour

Prof. Andrew Davies

Dr. Riad El-Fakih

Dr. Ali Alahmari

Prof. Andrew Davies

Dr. Brad Kahl

Prof. Michael Williams

Prof. David Maloney

DAY01 April 2021 THURSDAY

02 April 2021 FRIDAYDAY

KSA TIME ACTIVITY TITLE SPEAKER

KSA TIME ACTIVITY TITLE SPEAKER

1 - 4 APRILINTERNATIONAL

CONFERENCECME APPROVED

30CME APPROVED

30APPROVEDAPPROVED

SESSION 1 : HODGKIN LYMPHOMA Moderators: Dr. Majed Al Ahmadi & Dr. Mohsen Alzahrani

14:00 - 14:10 Conference Chairman’s Opening Remarks Dr. Mubarak Almansour

14:10 - 14:20 Welcome Address & Speakers Introduction Moderators

SESSION 6: CLL / MZL Moderators: Dr. Ahmed Alaskar & Dr. Ihab Al Hemaidi

14:20 – 14:50 How Do We Sequence Therapy for Marginal Zone Lymphomas?14:50 – 15:00 Discussion : Question & Answer15:00 – 15:20 The Rapidly Changing Landscape of CLL15:20 – 15:30 Discussion : Question & Answer 15:30 – 15:50 Satellite Symposium - Astellas Company Dr. Sameer Alamoudi "FLT3 Mutation and AML Burden: What Clinician Should Know"

SESSION 7: T-CELL LYMPHOMA Moderators: Dr. Musa Fares Alzahrani & Dr. Riyadh El-Fakih

15:50 - 16:20 Is it Time to Consider Chemotherapy-Free Treatments for Patients with

Peripheral T-Cell Lymphoma? Yes!

16:20 – 16:30 Discussion : Question & Answer

16:30 – 16:50 Asr Prayer Break

16:50 – 17:10 New Agents in the Treatment of Cutaneous T-Cell Lymphoma

17:10 – 17:20 Discussion : Question & Answer SESSION 8: CENTRAL NERVOUS SYSTEM LYMPHOMA Moderators: Dr. Amal Albehainy & Prof. Reyad Dada

17:20–17:50 Satellite Symposium - AstraZeneca Company Dr. Michael Wang

“Role of Acalabrutinib in MCL”

17:50 – 18:10 Who Should Receive Central Nervous System Prophylaxis in DLBCL?

18:10 – 18:20 Discussion: Question & Answer

18:20 – 18:40 The Evolving Treatments for Primary Central Nervous System Lymphoma

18:40 – 18:50 Discussion : Question & Answer

18:50 – 19:00 Wrap Up & Conclusion Moderators

19:00 Closing Remarks Dr. Mubarak Almansour

Prof. John Gribben

Prof. Owen O’Connors

Dr. Steven Horwitz

Dr. Joseph Connors

Dr. Andrés J. M Ferreri

Prof. Pier Luigi Zinzani

03 April 2021 SATURDAYDAY

19:00 – 19:15 Conference Chairman’s Opening Remarkss Dr. Mubarak Almansour

Welcome Address & Speakers Introduction Moderators SESSION 9: THERAPEUTIC Moderators: Dr. Amal Alabdulwahab, Dr. Khalil Farsi, & Dr. Roula Al Mufti

19:15 – 19:40 New Drugs on the Horizon in Lymphoma

19:40 – 19:50 Discussion : Question & Answer19:50 – 20:10 The Clinical Merits of Targeting PD-1/PDL1 in Non Hodgkin Lymphoma and Hodgkin Lymphoma

20:10 – 20:20 Discussion : Question & Answer

20:20 – 20:50 Satellite Symposium - MSD Company “Evolution of Immuno-therapy In the Management of RR cHL Latest Updates & Clinical Practice”

20:50 – 21:10 The Science Behind Targeting Immune Checkpoints in Lymphoma

21:10 – 21:20 Discussion : Question & Answer

21:20 – 21:40

21:40 – 21:50 Discussion : Question & Answer

21:50 – 22:00 Wrap Up & Conclusion Moderators

22:00 Closing Remarks Dr. Mubarak Almansour

Prof. Stephen Ansell

Dr. Alfadel Alshaibani

Prof. Stephen Ansell

Dr. Julie Vose

Prof. Owen O’Connors

KSA TIME ACTIVITY TITLE SPEAKER

KSA TIME ACTIVITY TITLE SPEAKER

1 - 4 APRILINTERNATIONAL

CONFERENCECME APPROVED

30

04 April 2021 SUNDAYDAY

4

CME APPROVED

30